Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.

Ades S, Douce D, Holmes CE, Cory S, Prior S, Butenas S, Callas P, Cushman M.

J Thromb Haemost. 2018 Jun;16(6):1099-1106. doi: 10.1111/jth.14004. Epub 2018 Apr 29.

PMID:
29575637
2.

Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.

Tuzlak S, Haschka MD, Mokina AM, Rülicke T, Cory S, Labi V, Villunger A.

FEBS J. 2018 Apr;285(8):1403-1418. doi: 10.1111/febs.14426. Epub 2018 Mar 24.

3.

MyGrief.ca.

Cory S.

Ann Palliat Med. 2018 Jan;7(Suppl 1):AB017. doi: 10.21037/apm.2018.s017.

4.

Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells.

Mensink M, Anstee NS, Robati M, Schenk RL, Herold MJ, Cory S, Vandenberg CJ.

Cell Death Differ. 2018 Mar;25(4):795-806. doi: 10.1038/s41418-017-0045-8. Epub 2018 Jan 16.

5.

The BCL-2 arbiters of apoptosis and their growing role as cancer targets.

Adams JM, Cory S.

Cell Death Differ. 2018 Jan;25(1):27-36. doi: 10.1038/cdd.2017.161. Epub 2017 Nov 3. Review.

6.

Mnt modulates Myc-driven lymphomagenesis.

Campbell KJ, Vandenberg CJ, Anstee NS, Hurlin PJ, Cory S.

Cell Death Differ. 2017 Dec;24(12):2117-2126. doi: 10.1038/cdd.2017.131. Epub 2017 Aug 11.

7.

Targeting BCL-2-like Proteins to Kill Cancer Cells.

Cory S, Roberts AW, Colman PM, Adams JM.

Trends Cancer. 2016 Aug;2(8):443-460. doi: 10.1016/j.trecan.2016.07.001. Epub 2016 Jul 30. Review.

PMID:
28741496
8.

Structure of human Fe-S assembly subcomplex reveals unexpected cysteine desulfurase architecture and acyl-ACP-ISD11 interactions.

Cory SA, Van Vranken JG, Brignole EJ, Patra S, Winge DR, Drennan CL, Rutter J, Barondeau DP.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5325-E5334. doi: 10.1073/pnas.1702849114. Epub 2017 Jun 20.

9.

Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo.

Carrington EM, Zhan Y, Brady JL, Zhang JG, Sutherland RM, Anstee NS, Schenk RL, Vikstrom IB, Delconte RB, Segal D, Huntington ND, Bouillet P, Tarlinton DM, Huang DC, Strasser A, Cory S, Herold MJ, Lew AM.

Cell Death Differ. 2017 May;24(5):878-888. doi: 10.1038/cdd.2017.30. Epub 2017 Mar 31.

10.

Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.

Anstee NS, Vandenberg CJ, Campbell KJ, Hughes PD, O'Reilly LA, Cory S.

Cell Death Differ. 2017 Mar;24(3):397-408. doi: 10.1038/cdd.2016.125. Epub 2016 Nov 4.

11.

Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice.

Bilardi RA, Anstee NS, Glaser SP, Robati M, Vandenberg CJ, Cory S.

Cell Death Dis. 2016 Sep 1;7(9):e2351. doi: 10.1038/cddis.2016.258.

12.

Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Cyr-Depauw C, Northey JJ, Tabariès S, Annis MG, Dong Z, Cory S, Hallett M, Rennhack JP, Andrechek ER, Siegel PM.

Mol Cell Biol. 2016 May 2;36(10):1509-25. doi: 10.1128/MCB.00600-15. Print 2016 May 15.

13.

FoxO3 suppresses Myc-driven lymphomagenesis.

Vandenberg CJ, Motoyama N, Cory S.

Cell Death Dis. 2016 Jan 14;6:e2046. doi: 10.1038/cddis.2015.396.

14.

Masterminding B Cells.

Cory S.

J Immunol. 2015 Aug 1;195(3):763-5. doi: 10.4049/jimmunol.1501277. No abstract available.

15.

Donald Metcalf: The father of modern hematology.

Adams JM, Cory S.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2628-9. doi: 10.1073/pnas.1500346112. Epub 2015 Feb 2. No abstract available.

16.

The prognostic ease and difficulty of invasive breast carcinoma.

Tofigh A, Suderman M, Paquet ER, Livingstone J, Bertos N, Saleh SM, Zhao H, Souleimanova M, Cory S, Lesurf R, Shahalizadeh S, Garcia Lopez N, Riazalhosseini Y, Omeroglu A, Ursini-Siegel J, Park M, Dumeaux V, Hallett M.

Cell Rep. 2014 Oct 9;9(1):129-142. doi: 10.1016/j.celrep.2014.08.073. Epub 2014 Oct 2.

17.

Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.

Vandenberg CJ, Waring P, Strasser A, Cory S.

Blood. 2014 Aug 14;124(7):1099-109. doi: 10.1182/blood-2014-04-570770. Epub 2014 Jul 1.

18.

Palliative care nursing in the virtual realm.

Stenekes S, Brown S, Hearson B, Cory S.

Int J Palliat Nurs. 2014 Apr;20(4):161-3. No abstract available.

PMID:
24763322
19.

Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer.

Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, Page BD, Gunning PT, Ferri LE, Hallett M, Park M.

Sci Signal. 2014 Apr 22;7(322):ra38. doi: 10.1126/scisignal.2004839.

PMID:
24757178
20.

Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice.

Vandenberg CJ, Josefsson EC, Campbell KJ, James C, Lawlor KE, Kile BT, Cory S.

Cell Death Differ. 2014 May;21(5):676-84. doi: 10.1038/cdd.2013.201. Epub 2014 Jan 24.

21.

Australian academy is fair to women.

Cory S.

Nature. 2013 May 23;497(7450):439. doi: 10.1038/497439c. No abstract available.

PMID:
23698433
22.

The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.

Ahn R, Sabourin V, Ha JR, Cory S, Maric G, Im YK, Hardy WR, Zhao H, Park M, Hallett M, Siegel PM, Pawson T, Ursini-Siegel J.

Cancer Res. 2013 Jul 15;73(14):4521-32. doi: 10.1158/0008-5472.CAN-12-4178. Epub 2013 May 21.

23.

ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.

Vandenberg CJ, Cory S.

Blood. 2013 Mar 21;121(12):2285-8. doi: 10.1182/blood-2013-01-475855. Epub 2013 Jan 22.

24.

ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.

Mourskaia AA, Amir E, Dong Z, Tiedemann K, Cory S, Omeroglu A, Bertos N, Ouellet V, Clemons M, Scheffer GL, Park M, Hallett M, Komarova SV, Siegel PM.

Breast Cancer Res. 2012 Nov 22;14(6):R149. doi: 10.1186/bcr3361.

25.

Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selection.

Campbell KJ, Gray DH, Anstee N, Strasser A, Cory S.

Cell Death Differ. 2012 Dec;19(12):1962-71. doi: 10.1038/cdd.2012.84. Epub 2012 Jun 29.

26.

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.

Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A, Zuo D, Madore J, Monast A, Mes-Masson AM, Grosset AA, Gaboury L, Hallet M, Siegel P, Park M.

Breast Cancer Res. 2012 May 8;14(3):R74.

27.

Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.

Mérino D, Khaw SL, Glaser SP, Anderson DJ, Belmont LD, Wong C, Yue P, Robati M, Phipson B, Fairlie WD, Lee EF, Campbell KJ, Vandenberg CJ, Cory S, Roberts AW, Ludlam MJ, Huang DC, Bouillet P.

Blood. 2012 Jun 14;119(24):5807-16. doi: 10.1182/blood-2011-12-400929. Epub 2012 Apr 26.

28.

BH3-only proteins in apoptosis at a glance.

Happo L, Strasser A, Cory S.

J Cell Sci. 2012 Mar 1;125(Pt 5):1081-7. doi: 10.1242/jcs.090514. Review. No abstract available.

29.

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.

Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F, Yu L, Fernandez SA, Pécot T, Rosol TJ, Cory S, Hallett M, Park M, Piper MG, Marsh CB, Yee LD, Jimenez RE, Nuovo G, Lawler SE, Chiocca EA, Leone G, Ostrowski MC.

Nat Cell Biol. 2011 Dec 18;14(2):159-67. doi: 10.1038/ncb2396.

30.

Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.

Franks SE, Campbell CI, Barnett EF, Siwicky MD, Livingstone J, Cory S, Moorehead RA.

Oncogene. 2012 Jul 5;31(27):3298-309. doi: 10.1038/onc.2011.486. Epub 2011 Oct 24.

31.

Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.

Strasser A, Cory S, Adams JM.

EMBO J. 2011 Aug 23;30(18):3667-83. doi: 10.1038/emboj.2011.307. Review.

32.

Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1.

Croker BA, O'Donnell JA, Nowell CJ, Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang JG, White M, Lackovic K, Cengia LH, O'Reilly LA, Bouillet P, Cory S, Strasser A, Roberts AW.

Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13135-40. doi: 10.1073/pnas.1110358108. Epub 2011 Jul 18.

33.

Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Ursini-Siegel J, Cory S, Zuo D, Hardy WR, Rexhepaj E, Lam S, Schade B, Jirstrom K, Bjur E, Piccirillo CA, Denardo D, Coussens LM, Brennan DJ, Gallagher WM, Park M, Pawson T, Hallett M, Muller WJ.

Cancer Res. 2010 Oct 15;70(20):7776-87. doi: 10.1158/0008-5472.CAN-10-2229. Epub 2010 Oct 5.

34.

Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.

Cory S, Ussery-Hall A, Griffin-Blake S, Easton A, Vigeant J, Balluz L, Garvin W, Greenlund K; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2010 Sep 24;59(8):1-37.

35.

Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.

Happo L, Cragg MS, Phipson B, Haga JM, Jansen ES, Herold MJ, Dewson G, Michalak EM, Vandenberg CJ, Smyth GK, Strasser A, Cory S, Scott CL.

Blood. 2010 Dec 9;116(24):5256-67. doi: 10.1182/blood-2010-04-280818. Epub 2010 Sep 9.

36.

Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, Metcalf D, Scott CL, Cory S.

Blood. 2010 Oct 28;116(17):3197-207. doi: 10.1182/blood-2010-04-281071. Epub 2010 Jul 14.

37.

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas.

Mason KD, Vandenberg CJ, Scott CL, Wei AH, Cory S, Huang DC, Roberts AW.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17961-6. doi: 10.1073/pnas.0809957105. Epub 2008 Nov 11.

38.

Use of the Massachusetts Youth Screening Instrument to assess mental health problems in young people within an Australian youth detention centre.

Stathis S, Letters P, Doolan I, Fleming R, Heath K, Arnett A, Cory S.

J Paediatr Child Health. 2008 Jul-Aug;44(7-8):438-43. doi: 10.1111/j.1440-1754.2008.01324.x.

PMID:
18564078
39.

Implementing arithmetic and other analytic operations by transcriptional regulation.

Cory SM, Perkins TJ.

PLoS Comput Biol. 2008 May 9;4(4):e1000064. doi: 10.1371/journal.pcbi.1000064.

40.

Effects on violence of laws and policies facilitating the transfer of youth from the juvenile to the adult justice system: a report on recommendations of the Task Force on Community Preventive Services.

Hahn R, McGowan A, Liberman A, Crosby A, Fullilove M, Johnson R, Moscicki E, Price L, Snyder S, Tuma F, Lowy J, Briss P, Cory S, Stone G; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2007 Nov 30;56(RR-9):1-11. Review.

41.

Distinct loci influence radiation-induced alveolitis from fibrosing alveolitis in the mouse.

Haston CK, Begin M, Dorion G, Cory SM.

Cancer Res. 2007 Nov 15;67(22):10796-803.

42.

Effectiveness of universal school-based programs to prevent violent and aggressive behavior: a systematic review.

Hahn R, Fuqua-Whitley D, Wethington H, Lowy J, Crosby A, Fullilove M, Johnson R, Liberman A, Moscicki E, Price L, Snyder S, Tuma F, Cory S, Stone G, Mukhopadhaya K, Chattopadhyay S, Dahlberg L; Task Force on Community Preventive Services.

Am J Prev Med. 2007 Aug;33(2 Suppl):S114-29.

PMID:
17675013
43.

Molecular dynamics simulations of glutamate diffusion in synaptic cleft.

Cory SM, Glavinovic MI.

Crit Rev Neurobiol. 2006;18(1-2):61-9.

PMID:
17725509
44.

The effectiveness of universal school-based programs for the prevention of violent and aggressive behavior: a report on recommendations of the Task Force on Community Preventive Services.

Hahn R, Fuqua-Whitley D, Wethington H, Lowy J, Liberman A, Crosby A, Fullilove M, Johnson R, Moscicki E, Price L, Snyder SR, Tuma F, Cory S, Stone G, Mukhopadhaya K, Chattopadhyay S, Dahlberg L; Centers for Disease Control and Prevention (CDC); Task Force on Community Preventive Services.

MMWR Recomm Rep. 2007 Aug 10;56(RR-7):1-12. Review.

45.

Interfacial interactions of glutamate, water and ions with carbon nanopore evaluated by molecular dynamics simulations.

Cory SM, Liu Y, Glavinović MI.

Biochim Biophys Acta. 2007 Sep;1768(9):2319-41. Epub 2007 Jun 15.

46.

Bcl-2-regulated apoptosis: mechanism and therapeutic potential.

Adams JM, Cory S.

Curr Opin Immunol. 2007 Oct;19(5):488-96. Epub 2007 Jul 12. Review.

47.

Intestinal phenotype of variable-weight cystic fibrosis knockout mice.

Canale-Zambrano JC, Poffenberger MC, Cory SM, Humes DG, Haston CK.

Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G222-9.

48.

Effects on violence of laws and policies facilitating the transfer of juveniles from the juvenile justice system to the adult justice system: a systematic review.

McGowan A, Hahn R, Liberman A, Crosby A, Fullilove M, Johnson R, Moscicki E, Price L, Snyder S, Tuma F, Lowy J, Briss P, Cory S, Stone G; Task Force on Community Preventive Services.

Am J Prev Med. 2007 Apr;32(4 Suppl):S7-28. Review.

PMID:
17386331
49.

The Bcl-2 apoptotic switch in cancer development and therapy.

Adams JM, Cory S.

Oncogene. 2007 Feb 26;26(9):1324-37. Review.

50.

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, Adams JM, Roberts AW, Huang DC.

Cancer Cell. 2006 Nov;10(5):389-99.

Supplemental Content

Support Center